Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Hong Kong Tech Press.
Press releases published on October 10, 2025
The Capital Link Announces Investigation Into the LuxUrban Story - The $300 Million Hotel Startup That Paid Workers 115% of Their Wages While the City Never Paid Up
San Diego, CA, Oct. 10, 2025 (GLOBE NEWSWIRE) -- The Capital Link is proud to spotlight a powerful investigative feature from Legal Tech Spotlight, unpacking the dramatic rise, fall, and potential rebirth of LuxUrban Hotels, the once-$300 million startup …
Rezolve Ai PLC Announces Shareholder Transfer to a New Global Institutional Investor
NEW YORK, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai PLC (NASDAQ: RZLV) (“Rezolve Ai” or the “Company”) today announced that DBLP Sea Cow Limited, a shareholder associated with the estate of the late John Wagner and Rezolve Chairman and CEO Dan Wagner, …
Greenhawk Terminates Option Agreement on Greenland Properties
TORONTO, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Greenhawk Resources Inc. (“Greenhawk” or the "Company") (CSE: GRHK) announces that it has terminated the arm’s length Option and Joint Venture Agreement dated May 21, 2025 (the “Agreement”) with 1531323 BC Ltd. (“ …
Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on October 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of …
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today …
Cerence Announces Equity Grant to Employee Under Inducement Plan Pursuant to Nasdaq Listing Rule 5635(c)(4)
BURLINGTON, Mass., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (the “Company” or “Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced that, in connection with Raja Bose’s recent appointment …
WiSA Fortifies Offerings and Strategy to Further Address Growing Home Audio Categories with Low-Cost Transmitter Module, WiSA Connect Mobile Application, and Interoperability Self-Certification Process
BEAVERTON, Ore., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Datavault AI (NASDAQ: DVLT), through its Acoustic Science Division’s Wireless Sound Association (WiSA), today announced three new key components to their assortment of industry-leading solutions: WiSA E …
Varonis Announces Date of Third Quarter 2025 Financial Results
MIAMI, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Varonis Systems, Inc. (Nasdaq: VRNS), the leader in data security, announced that it will report its third quarter 2025 financial results following the close of the U.S. financial markets Tuesday, October 28, 2025. …
Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $345 Million
SAN FRANCISCO and BOSTON, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for best-in-class profiles in the largest inflammatory and …
WiSA Fortifies Offerings and Strategy to Further Address Growing Home Audio Categories with Low-Cost Transmitter Module, WiSA Connect Mobile Application, and Interoperability Self-Certification Process
BEAVERTON, Ore., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Datavault AI (NASDAQ: DVLT), through its Acoustic Science Division’s Wireless Sound Association (WiSA), today announced three new key components to their assortment of industry-leading solutions: WiSA E …
FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder
FDA approves UZEDY® (risperidone) extended-release injectable suspension for subcutaneous use as monotherapy or as adjunctive therapy to lithium or valproate for the maintenance treatment of bipolar I disorder in adults.1 UZEDY (risperidone) extended- …
Legal Tech Spotlight Investigates Legal Turmoil Surrounding LuxUrban Hotels
New York, NY, Oct. 10, 2025 (GLOBE NEWSWIRE) -- In a newly released investigative feature, Legal Tech Spotlight examines how a single Midtown Manhattan email confirming a hotel lease evolved into a year-long saga of lawsuits, sensational headlines, and …
Comcast Contributes $75,000 to Boys & Girls Clubs of Silicon Valley to Uplift the Youth of Santa Clara County
San Jose, California, United States, Oct. 10, 2025 (GLOBE NEWSWIRE) -- The contribution towards programming that fosters digital opportunity was announced at the 2025 International Day of the Girl Celebration Comcast announced a $75,000 donation to the …
Valley Children’s Healthcare Becomes Exclusive Healthcare Partner of CIF Central Section
Sacramento, CA, Oct. 10, 2025 (GLOBE NEWSWIRE) -- CIF Sports Properties and Valley Children’s Healthcare have announced a four-year partnership, running through 2029, naming Valley Children’s as the exclusive healthcare partner of the CIF Central Section. …
ZenaTech anuncia la adquisición de Putt Land Surveying Inc., con sede en Tucson, y acelera el crecimiento de su negocio de Drones como Servicio (DaaS) en el área de Phoenix y en todo Arizona
VANCOUVER, Columbia Británica, Oct. 10, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), ”), proveedor de soluciones tecnológicas empresariales especializado en drones con inteligencia artificial (IA), Drone como …
AB Science today reports its revenues for the first half of 2025 and provides an update on its activities
PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2025 AND KEY EVENTS DURING THE PERIOD Financial and corporate situation Operating deficit reduced by 24% compared to the first half of 2024, amounting to €2.7 million as …
AB Science annonce aujourd’hui ses résultats financiers semestriels au 30 juin 2025 et présente un point sur ses activités
COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS FINANCIERS AU PREMIER SEMESTRE 2025 ET LES EVENEMENTS CLEFS DE LA PERIODE Situation financière et corporate Réduction du déficit opérationnel de 24% par rapport au premier semestre 2024, s’ …
Cegedim: Release of its 2025 Interim Financial Report
Financial Information Cegedim: Release of its 2025 Interim Financial Report Boulogne-Billancourt, October 10, 2025 Cegedim, an innovative technology and services group, announces that its Financial report for the 1st Half of 2025 is available free of …
Cegedim : Publication du Rapport Financier Semestriel 2025
COMMUNIQUÉ DE PRESSE Information financière Cegedim : Publication du Rapport Financier Semestriel 2025 Boulogne-Billancourt, le 10 octobre 2025 Cegedim, groupe innovant de technologies et de services, annonce que son Rapport Financier Semestriel …